{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:47:34Z","timestamp":1789001254079,"version":"build-2803163510"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100018262","name":"Intercept Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018262","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10620-021-07219-4","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T10:04:21Z","timestamp":1631181861000},"page":"4170-4180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5931-3058","authenticated-orcid":false,"given":"Jia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueren","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Bowlus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Rodriguez-Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Romanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina V.","family":"Haller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"VanWormer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Boscarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihe G.","family":"Daida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Sahota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Han Hank","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri","family":"Trudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loralee B.","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Melkonian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart C.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"For the FOLD Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"7219_CR1","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","volume":"386","author":"EJ Carey","year":"2015","unstructured":"Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015;386:1565\u20131575. https:\/\/doi.org\/10.1016\/S0140-6736(15)00154-3.","journal-title":"Lancet."},{"key":"7219_CR2","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","volume":"55","author":"C Corpechot","year":"2011","unstructured":"Corpechot C, Chazouilleres O, Poupon R. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J Hepatol. 2011;55:1361\u20131367. https:\/\/doi.org\/10.1016\/j.jhep.2011.02.031.","journal-title":"J Hepatol."},{"key":"7219_CR3","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S2468-1253(18)30163-8","volume":"3","author":"M Carbone","year":"2018","unstructured":"Carbone M, Nardi A, Flack S et al. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score. Lancet Gastroenterol Hepatol. 2018;3:626\u2013634. https:\/\/doi.org\/10.1016\/S2468-1253(18)30163-8.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"7219_CR4","doi-asserted-by":"publisher","unstructured":"Cheung AC, Lammers WJ, Murillo Perez CF, et al. Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2019; Doi:https:\/\/doi.org\/10.1016\/j.cgh.2018.12.028","DOI":"10.1016\/j.cgh.2018.12.028"},{"key":"7219_CR5","doi-asserted-by":"publisher","unstructured":"Lu M, Zhou Y, Haller IV, et al. Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2018;16:1342\u20131350 e1. Doi:https:\/\/doi.org\/10.1016\/j.cgh.2017.12.033","DOI":"10.1016\/j.cgh.2017.12.033"},{"key":"7219_CR6","doi-asserted-by":"publisher","unstructured":"Lu M, Li J, Haller IV, et al. Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2018;16:1333\u20131341 e6. https:\/\/doi.org\/10.1016\/j.cgh.2017.10.018","DOI":"10.1016\/j.cgh.2017.10.018"},{"key":"7219_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.14309\/ajg.0000000000000512","volume":"115","author":"SC Gordon","year":"2020","unstructured":"Gordon SC, Wu KH, Lindor K et al. Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis. Am J Gastroenterol. 2020;115:262\u2013270. https:\/\/doi.org\/10.14309\/ajg.0000000000000512.","journal-title":"Am J Gastroenterol."},{"key":"7219_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jaut.2013.07.005","volume":"46","author":"A Tanaka","year":"2013","unstructured":"Tanaka A, Takikawa H. Geoepidemiology of primary sclerosing cholangitis: a critical review. J Autoimmun. 2013;46:35\u201340. https:\/\/doi.org\/10.1016\/j.jaut.2013.07.005.","journal-title":"J Autoimmun."},{"key":"7219_CR9","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1478-3231.2006.01304.x","volume":"26","author":"H Nyblom","year":"2006","unstructured":"Nyblom H, Bjornsson E, Simren M, Aldenborg F, Almer S, Olsson R. The AST\/ALT ratio as an indicator of cirrhosis in patients with PBC. Liver international\u202f: official journal of the International Association for the Study of the Liver. 2006;26:840\u2013845. https:\/\/doi.org\/10.1111\/j.1478-3231.2006.01304.x.","journal-title":"Liver international : official journal of the International Association for the Study of the Liver."},{"key":"7219_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/1751-2980.12787","volume":"20","author":"V Ronca","year":"2019","unstructured":"Ronca V, Gerussi A, Cristoferi L, Carbone M, Invernizzi P. Precision medicine in primary biliary cholangitis. Journal of Digestive Diseases. 2019;20:338\u2013345. https:\/\/doi.org\/10.1111\/1751-2980.12787.","journal-title":"Journal of Digestive Diseases."},{"key":"7219_CR11","doi-asserted-by":"crossref","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys. Wiley series in probability and mathematical statistics Applied probability and statistics,. Wiley. 1987;xxix","DOI":"10.1002\/9780470316696"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07219-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-07219-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07219-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T17:26:49Z","timestamp":1657906009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-07219-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["7219"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-07219-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"19 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Stuart C. Gordon receives grant\/research support from AbbVie Pharmaceuticals, Conatus, CymaBay, Gilead Pharmaceuticals, Intercept Pharmaceuticals, and Merck. Mei Lu, Jia Li, Lora Rupp, Sheri Trudeau, Yueren Zhou, Christina Melkonian, Yihe G. Daida, Mark A. Schmidt, and Joseph A. Boscarino receive grant\/research support from Gilead Pharmaceuticals. Carla V. Rodriguez owns stock in Gilead (<\u2009$5,000). Heather Anderson receives grant\/research support from Intercept Pharmaceuticals. Jeffrey J. VanWormer receives grant\/research support from Retrophin. Christopher L. Bowlus receives grant\/research support from AbbVie Pharmaceuticals, Bristol-Myers-Squibb, Gilead Biosciences, Intercept Pharmaceuticals, Merck, Shire Pharmaceuticals, Takeda Pharmaceuticals, and has served as an advisor for Bristol-Myers-Squibb, Gilead Biosciences, Intercept Pharmaceuticals, and Takeda. Keith Lindor is a consultant\/advisor for Biopharma and has served as an ad hoc advisor for HighTide, Takeda, Shire, and Intercept Pharmaceuticals. He sits on a Data Safety Monitoring Board for Takeda. Robert J. Romanelli receives received grant\/research support from Pfizer Inc. and Janssen Scientific Affairs. Irina V. Haller, Marsha A. Raebel, and Jennifer Vincent have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}